SCR-1481B1
SCR-1481B1 is a dual-action small molecule inhibitor targeting both c-Met and VEGFR kinases. It is utilized in cancer research to study tumor growth and angiogenesis, showing efficacy in both cellular assays and animal models of cancers driven by these pathways.
Product Specifications
CAS Number
1174161-86-4
Product Name Alternative
SCR 1481B1, SCR1481B1, SCR-1481B1, SCR-1481B-1, Vascular endothelial growth factor receptor, VEGFR, VEGFR1, inhibit, HGFR, Inhibitor, cMet, cMet/HGFR, c-Met/HGFR, c-Met inhibitor 2, c-Met
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.07% (May vary between batches)
Solubility
DMSO:31 mg/mL (37.75 mM)
Smiles
NC (CO) (CO) CO.NC (CO) (CO) CO.Nc1nccc (Oc2ccc (NC (=O) c3cn (COP (O) (O) =O) cc (-c4ccc (F) cc4) c3=O) cc2F) c1Cl
Molecular Formula
C32H40ClF2N6O13P
Molecular Weight
821.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
138458-PE 100 µL
TP53 (Tumor Suppressor p53, Cellular Tumor Antigen p53, TRP53, Antigen NY-CO-13, BCC7, LFS1, Phosphoprotein p53) (PE) discontinued
Sign In for Pricing
View Details 
